In the current study, okadaic acid inhibited STAT3 serine dephosphorylation induced by pasireotide (Figure 6) suggesting that this analog can act through phosphatase 2A in pituitary tumor cells carrying the FGFR4-R388 SNP. Here, FGFR4 is linked to pituitary tumor.